First Choice Home Infusion, Llc
Home Infusion Therapy Pharmacy
600 Commons Dr Ste 101, Gallatin
Tennessee, 37066-6331
615-824-1216 First Choice Home Infusion, Llc is an authorized DME supplier for medicare equipments and products.
First Choice Home Infusion, Llc is a Home Infusion Therapy Pharmacy in Gallatin, Tennessee. It is located at 600 Commons Dr Ste 101, Gallatin and it's customer support contact number is 615-824-1216. The authorized person of First Choice Home Infusion, Llc is Mr. Mark Duane Osborne who is Managing Member of the pharmacy and his contact number is 615-351-3604. Active license number of First Choice Home Infusion, Llc is 5294 for Home Infusion Therapy Pharmacy in Tennessee. First Choice Home Infusion, Llc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
First Choice Home Infusion, Llc is pharmacy-based, decentralized patient care organization with expertise in USP 797-compliant sterile drug compounding that provides care to patients with acute or chronic conditions generally pertaining to parenteral administration of drugs, biologics and nutritional formulae administered through catheters and/or needles in home and alternate sites. Extensive professional pharmacy services, care coordination, infusion nursing services, supplies and equipment are provided to optimize efficacy and compliance.
Pharmacy Details:
First Choice Home Infusion, Llc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
| Name: | First Choice Home Infusion, Llc |
| Type: | Home Infusion Therapy Pharmacy |
| Location: | 600 Commons Dr Ste 101, Gallatin, Tennessee, 37066-6331 |
| Phone: | 615-824-1216 |
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
| Name: | Mr. Mark Duane Osborne |
| Position: | Managing Member |
| Contact Number: | 615-351-3604 |
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
| NPI Number: | 1366854788 |
| NPI Enumeration Date: | 21 May, 2014 |
| NPI Last Update On: | 16 Feb, 2021 |
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for First Choice Home Infusion, Llc are as mentioned below.
| Specialization | License Number | State | Status | |
| Home Infusion Therapy Pharmacy | 5294 | Tennessee | Primary | |
| Mail Order Pharmacy | 5294 | Tennessee | Secondary | |
| Specialty Pharmacy | 5294 | Tennessee | Secondary | |
Medicare Enrollment:
First Choice Home Infusion, Llc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
| PAC ID: |
Enrollment ID: |
Org Name | Medicare Entity Type |
| 1951627256 | O20150304001208 | First Choice Home Infusion Llc | PART B SUPPLIER - OTHER |
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
| Address: | 600 Commons Dr Ste 101, Gallatin, Tennessee |
| Zip: | 37066-6331 |
| Phone Number: | 615-351-3604 |
| Fax Number: | 844-324-3244 |
Patients can reach First Choice Home Infusion, Llc at
600 Commons Dr Ste 101, Gallatin, Tennessee or can
call on customer care at 615-824-1216.
Comments/ Reviews:
Read all the reviews posted for First Choice Home Infusion, Llc below. You may also share your own experience with First Choice Home Infusion, Llc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.